Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free
Discussion Forum: Awakn Life Sciences Corp.
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM-NR - Jul 05, 2022 07:42AM
Icon agoracom Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development…

0
AGORACOM-NR
Jul 05, 2022 07:42AM
AGORACOM-NR - Jul 04, 2022 04:00PM
Icon agoracom END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 18% On 23K SHARES

0
AGORACOM-NR
Jul 04, 2022 04:00PM
AGORACOM-NR - Jun 17, 2022 09:03AM
Icon agoracom Awakn Life Sciences to Present in Upcoming June 2022 Conferences

0
AGORACOM-NR
Jun 17, 2022 09:03AM
AGORACOM-NR - Jun 15, 2022 04:53PM
Icon agoracom END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 29% On 81K SHARES

0
AGORACOM-NR
Jun 15, 2022 04:00PM
AGORACOM-NR - Jun 14, 2022 05:00PM
Icon agoracom Awakn Life Sciences Reports Results for Quarter Ended April 30, 2022

0
AGORACOM-NR
Jun 14, 2022 04:00PM
AGORACOM-NR - Jun 07, 2022 07:30AM
Icon agoracom Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO

0
AGORACOM-NR
Jun 07, 2022 07:30AM
AGORACOM-NR - Apr 13, 2022 07:30AM
Icon agoracom Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

1
run3donlineaz
Jun 01, 2022 05:46AM
AGORACOM-NR - May 26, 2022 07:30AM
Icon agoracom Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application for the Treatment of Behavioral Addictions

0
AGORACOM-NR
May 26, 2022 07:30AM
AGORACOM-NR - May 24, 2022 07:30AM
Icon agoracom Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for 'The Investor Hotseat' via Live Stream on May 26th

0
AGORACOM-NR
May 24, 2022 07:30AM
AGORACOM-NR - May 19, 2022 07:56AM
Icon agoracom Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions

0
AGORACOM-NR
May 19, 2022 07:56AM
AGORACOM-NR - Apr 28, 2022 04:28PM
Icon agoracom Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

0
AGORACOM-NR
Apr 28, 2022 04:28PM
AGORACOM-NR - Apr 06, 2022 07:30AM
Icon agoracom Awakn Successfully Completes Phase One of Its Drug Discovery Program

0
AGORACOM-NR
Apr 06, 2022 07:30AM
AGORACOM-NR - Apr 05, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate in Upcoming April 2022 Conferences

0
AGORACOM-NR
Apr 05, 2022 07:30AM
AGORACOM-NR - Mar 22, 2022 07:30AM
Icon agoracom Awakn Life Sciences Announces Closing of Private Placement

0
AGORACOM-NR
Mar 22, 2022 07:30AM
AGORACOM-NR - Mar 17, 2022 08:30AM
Icon agoracom Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments

0
AGORACOM-NR
Mar 17, 2022 07:30AM
AGORACOM-NR - Mar 15, 2022 07:30AM
Icon agoracom Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development

0
AGORACOM-NR
Mar 15, 2022 07:30AM
AGORACOM - Mar 09, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate at Upcoming March 2022 Conferences

0
AGORACOM
Mar 09, 2022 07:30AM
AGORACOM-NR - Feb 10, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Host Fireside Chat with Dr. Ben Sessa, Chief Medical Officer, on March 2nd at 11:00am EST

1
cookieclickeraz
Mar 01, 2022 11:59PM
AGORACOM-NR - Feb 15, 2022 07:30AM
Icon agoracom Awakn Life Sciences' Professor Celia Morgan Named One of the Most Influential Women in the Psychedelics Industry

1
cookieclickeraz
Mar 01, 2022 11:58PM
AGORACOM-NR - Feb 17, 2022 07:45AM
Icon agoracom Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules

0
AGORACOM-NR
Feb 17, 2022 07:45AM
New Message